Publicaciones en colaboración con investigadores/as de Universidade da Coruña (27)

2024

  1. Therapeutic management of CNIC polypill at discharge from a first acute coronary syndrome in Spain: The PANDORA study

    REC: CardioClinics, Vol. 59, Núm. 4, pp. 266-277

2022

  1. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry

    Expert Opinion on Pharmacotherapy, Vol. 23, Núm. 12, pp. 1457-1465

  2. Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry

    Frontiers in Cardiovascular Medicine, Vol. 9

2021

  1. Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry

    European Journal of Clinical Investigation, Vol. 51, Núm. 4

  2. Relationship between multimorbidity and outcomes in atrial fibrillation

    Experimental Gerontology, Vol. 153

2020

  1. Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry

    Journal of the American Heart Association, Vol. 9, Núm. 1

  2. Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study

    Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 14-20

  3. INR during stroke and bleeding in patients with atrial fibrillation and on vitamin K antagonists

    REC: CardioClinics, Vol. 55, Núm. 3, pp. 131-138

  4. Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study

    European Journal of Internal Medicine, Vol. 78, pp. 63-68

  5. Prognostic impact of inappropriate doses of direct oral anticoagulants in clinical practice

    Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 329-330

  6. Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry

    Annals of Medicine, Vol. 52, Núm. 6, pp. 300-309

2018

  1. Inappropriate doses of direct oral anticoagulants in real-world clinical practice: Prevalence and associated factors. A subanalysis of the FANTASIIA registry

    Europace, Vol. 20, Núm. 10, pp. 1577-1583

  2. Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU

    Revista Espanola de Cardiologia, Vol. 71, Núm. 7, pp. 553-564

  3. Quality of oral anticoagulation with Vitamin K antagonists in 'real-world' patients with atrial fibrillation: A report from the prospective multicentre FANTASIIA registry

    Europace, Vol. 20, Núm. 9, pp. 1435-1441

  4. Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry

    Thrombosis and Haemostasis, Vol. 118, Núm. 2, pp. 279-287

  5. Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from FANTASIIA Registry

    European Journal of Clinical Investigation, Vol. 48, Núm. 5

2017

  1. Differences in the Characteristics and Management of Patients With Atrial Fibrillation Followed-up by Cardiologists and Other Specialists

    Revista Espanola de Cardiologia, Vol. 70, Núm. 10, pp. 883-886

  2. Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation

    American Journal of Cardiology, Vol. 120, Núm. 12, pp. 2176-2181

2016

  1. Cardiopatía estructural en pacientes anticoagulados con fibrilación auricular no valvular: prevalencia y perfil clínico en una muestra nacional

    Revista Espanola de Cardiologia, Vol. 69, Núm. 10, pp. 986-990

  2. Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 21, Núm. 2, pp. 150-156